NCT01471834View on ClinicalTrials.gov

Verification of the Efficacy and Safety of the BAROSTIM NEO System in the Treatment of Drug Resistant Hypertension

NAActive, not recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

May 31, 2012

Study Completion Date

August 31, 2026

Conditions
High Blood Pressure
Interventions
DEVICE

BAROSTIM NEO System

DRUG

Medical Management

Trial Locations (9)

30625

Midizinische Hochschule Hannover, Hanover

37075

Goettingen-Georg August University, Göttingen

40225

University Hospital Duesseldorf, Düsseldorf

50924

University Hospital Cologne, Cologn

T2N 2T9

University of Calgary, Calgary

T2P 1C4

University of Alberta - Edmonton, Edmonton

N6G 2V2

London-Lawson Health Research Institute, London

04129

Klinkum St. George Leipzig, Leipzig

HX6229

Maastricht University, Maastricht

Sponsors

Lead Sponsor

CVRx, Inc.
All Listed Sponsors
lead

CVRx, Inc.

INDUSTRY

NCT01471834 - Verification of the Efficacy and Safety of the BAROSTIM NEO System in the Treatment of Drug Resistant Hypertension | Biotech Hunter | Biotech Hunter